Medical Article

Asahi Kasei’s Hovilpri is now approved for treating lesions caused by herpes simplex virus infection. This daily pill came from the $919 million acquisition of AiCuris Anti-Infective Cures. The post Asahi Kasei Acquisition Pays Off With FDA Approval for Novel Herpes Drug appeared first on MedCity News.

Outro’s funding included participation from Listen Ventures, Cake Ventures, Jason Calicanis’s LAUNCH, Actions Capital, Hannah Grey Ventures, SemperVirens, Brock Recovery Group and Pave Health Ventures. The post Outro Raises $7M To Support Safe Deprescribing appeared first on MedCity News.

Investing in pediatric care is not simply a moral imperative. It is one of the most practical long-term investments the healthcare system can make. The post Pediatric Innovation Isn’t a Small-Market Problem, It’s an Incentive Problem appeared first on MedCity News.

Asking the right questions about community support, caregiving responsibilities, emotional well-being, and the availability of trusted social networks can establish important context for a person’s outcomes — and spark conversations about social needs that might never otherwise take place. The post Loneliness And Diabetes: Harnessing an Opportunity for Better Outcomes appeared first on MedCity News.

Register for INVEST Digital Health, scheduled for October 29 in Dallas, for an engaging discussion on the impact of consumer-centered care from diagnostics to employer benefits and more. The post Join Us at INVEST Digital Health for a Conversation on Consumer-Centered Care across the Healthcare Ecosystem appeared first on MedCity News.

The FDA recently published draft guidance on pre-market testing for robotically-assisted surgical devices, raising timely discussion around whether hospital infrastructures are capable of supporting increasingly complex systems.  The post Are Hospital Operating Rooms Ready For FDA’s Expectations for Surgical Robots? appeared first on MedCity News.